ABT250110P99000
- 0.00
- 0.000.00%
Abbott Laboratories Newsroom
8 Health Care Stocks Whale Activity In Today's Session
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $138
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Wells Fargo Sticks to Their Buy Rating for Abbott Laboratories (ABT)
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt
Catalyst Watch: CES, M&A Votes and the Supreme Court Tackles the TikTok Case
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
Abbott Hosts Conference Call for Fourth-Quarter Earnings
After experiencing a bumper harvest in 2024, the USA ETF may encounter setbacks this year.
The USA Exchange Traded Fund (ETF) received a record inflow of $1.1 trillion in 2024, but entering 2025, rapid growth may face more obstacles.
Evercore Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $136
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
How Is The Market Feeling About Abbott Laboratories?
5 MedTech Stocks That Are Poised to Beat the Market in 2025